Article Versions Notes

Sunoqrot S, Alfaraj M, Hammad AM, Kasabri V, Shalabi D, Deeb AA, Hasan Ibrahim L, Shnewer K, Yousef I. Development of a Thymoquinone Polymeric Anticancer Nanomedicine through Optimization of Polymer Molecular Weight and Nanoparticle Architecture. Pharmaceutics. 2020; 12(9):811. https://doi.org/10.3390/pharmaceutics12090811

Sunoqrot, Suhair, Malek Alfaraj, Ala’a M. Hammad, Violet Kasabri, Dana Shalabi, Ahmad A. Deeb, Lina Hasan Ibrahim, Khaldoun Shnewer, and Ismail Yousef. 2020. "Development of a Thymoquinone Polymeric Anticancer Nanomedicine through Optimization of Polymer Molecular Weight and Nanoparticle Architecture" Pharmaceutics 12, no. 9: 811. https://doi.org/10.3390/pharmaceutics12090811

Sunoqrot, S., Alfaraj, M., Hammad, A. M., Kasabri, V., Shalabi, D., Deeb, A. A., Hasan Ibrahim, L., Shnewer, K., & Yousef, I. (2020). Development of a Thymoquinone Polymeric Anticancer Nanomedicine through Optimization of Polymer Molecular Weight and Nanoparticle Architecture. Pharmaceutics, 12(9), 811. https://doi.org/10.3390/pharmaceutics12090811